Bridge Medicines

New York
New York
United States

Show jobs for this employer

About Bridge Medicines

Bridge Medicines is a pioneering drug-discovery company focused on advancing promising early technologies in major academic institutions from human proof-of-concept to clinical development. Launched by Memorial Sloan Kettering Cancer Center, The Rockefeller University, Weill Cornell Medicine and Takeda Pharmaceutical Company Ltd., in partnership with Deerfield Management and Bay City Capital, Bridge Medicines is a groundbreaking initiative that provides an unbroken, fully funded and professionally staffed path from discovery to drug candidate.
YEAR FOUNDED:
October 2016
LEADERSHIP:
CEO: William J. Polvino

5 articles about Bridge Medicines